Kerry J Flom is an accomplished executive with extensive experience in clinical affairs and regulatory submissions, currently serving as Executive Vice President and Chief Regulatory Officer at Cepheid since 2013. Previously, Kerry held senior roles at Cepheid from 2004 to 2012, focusing on infectious disease, oncology, and genetics MDx clinical trials. Prior to Cepheid, Kerry worked as Senior Director of Clinical Affairs/Submissions at Vysis/Abbott Molecular and held director positions at Baxter Healthcare Inc. and Oncor Inc. Kerry's academic credentials include a Ph.D. in Biochemistry and a Ph.D. in Microbiology from the University of Illinois Urbana-Champaign, where studies were completed between 1975 and 1981.